Arginine-cysteine polymorphism at codon 264 of the human CYP19 gene does not affect aromatase activity

Pharmacogenetics

Volumn 7, Issue 5, 1997, Pages 419-424

  Watanabe, Junko ^a   Harada, Nobuhiro ^b   Suemasu, Kimito ^a   Higashi, Yasuhiro ^a   Gotoh, Osamu ^a   Kawajiri, Kaname ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Aromatase inhibitor; Breast cancer; Cytochrome P450(arom); Genetic polymorphism

Indexed keywords

AROMATASE;

BREAST CANCER; ENZYME ACTIVITY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JAPAN; MUTATION; MUTATION RATE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; ARGININE; AROMATASE; CODON; COS CELLS; CYSTEINE; GENOTYPE; HUMANS; KINETICS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 0030853581     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199710000-00014     Document Type: Short Survey

References (23)

1. Corbin CJ, Graham-Lorence S, McPhaul M, Mason JI, Mendelson CR, Simpson ER. Isolation of a full-length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in nonsteroidogenic cells. Proc Natl Acad Sci USA 1988: 85, 8948-8952.
2. Covey DF, Hood WF, Parikh VD. 10β-Propynyl-substituted Steroids. J Biol Chem 1981: 256, 1076-1079.
3. Goss PE, Powles TJ, Dowsett M, Hutchison G, Brodie AM, Gazet J-C, Coombes RC. Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report. Cancer Res 1986: 46, 4823-4826.
4. Gotoh O. Substrate recognition sites in cytochrome P450 family 2(CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. J Biol Chem 1992: 267, 83-90.
5. Graham-Lorence S, Khalil MW, Lorence MC, Mendelson CR, Simpson ER. Structure-function relationships of human aromatase cytochrome P-450 using molecular modeling and site directed mutagenesis. J Biol Chem 1991: 266, 11939-11946.
6. Graham-Lorence S, Amarneh B, White RE, Peterson JA, Simpson ER. A three-dimensional model of aromatase cytochrome P450. Protein Science 1995: 4, 1065-1080.
7. Harada N. Cloning of a complete cDNA encoding human aromatase: Immunochemical identification and sequence analysis. Biochem Biophys Res Commun 1988: 156, 725-732.
8. arom) deficiency. J Biol Chem 1992: 267, 4781-4785.
9. Ito Y, Fisher CR, Conte FA, Grumbach MM, Simpson ER. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc Natl Acad Sci USA 1993: 90, 11673-11677.
10. Kao Y-C, Cam LL, Laughton CA, Zhou D, Chen S. Binding characteristics of seven inhibitors of human aromatase: A site-directed mutagenesis study. Cancer Res 1996: 56, 3451-3460.
11. Kawajiri K, Watanabe J, Eguchi H, Nakachi K, Kiyohara C, Hayashi S-I. Polymorphisms of human Ah receptor gene are not involved in lung cancer. Pharmacogenetics 1995: 5, 151-158.
12. Killinger DW, Perel E, Daniilescu D, Kharlip L, Blackatein ME. Aromatase activity in the breast and other peripheral tissues and its therapeutic regulation. Steroids 1987: 50, 523-535.
13. Means GD, Mahendroo MS, Corbin CJ, Mathis JM, Powell FE, Mendelson CR, Simpson ER. Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. J Biol Chem 1989: 264, 19385-19391.
14. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a noval mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995: 80, 3689-3698.
15. Nakachi K, Imai K, Hayashi SI, Watanabe J, Kawajiri K. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 1991: 51, 5177-5180.
16. Santen RJ, Santner S, Davis B, Veldhuis J, Samojlik E, Ruby F. Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma. J Clin Endocrinol Metab 1978: 47, 1257-1265.
17. Schieweck K, Bhatnagar AS, Matter A. CGS 16949A, a new non-steroidal aromatase inhibitor: effects on hormone-dependent and -independent tumors in vivo. Cancer Res 1988: 48, 834-838.
18. Silva MC, Rowlands MG, Dowsett M, Gusterson B, Mckinna JA, Fryatt I, Coombes RC. Intratumoral aromatase as a prognostic factor in human breast carcinoma. Cancer Res 1989: 49, 2588-2591.
19. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, Amarneh B, Ito Y, Fischer CR, Michael MD et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocrine Rev 1994: 15, 342-355.
20. Thompson EA Jr, Siiteri PK. Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione. J Biol Chem 1974: 249, 5364-5372.
21. Toda K, Terashima M, Mitsuuchi Y, Yamasaki Y, Yokoyama Y, Nojima S, Ushiro H, Maeda T, Yamamoto Y, Sagara Y, Shizuta Y. Alternative usage of different poly (A) addition signals for two major species of mRNA encoding human aromatase P-450. FEBS Lett 1989: 247, 371-376.
22. Zhou D, Korzekwa KR, Poulos T, Chen S. A site-directed mutagenesis study of human placental aromatase. J Biol Chem 1992: 267, 762-768.
23. Zhou D, Cam LL, Laughton CA, Korzekawa KR, Chen S. Mutagenesis study at a postulated hydrophorbic region near the active site of aromatase cytochrome P450. J Biol Chem 1994: 269, 19501-19508.